2008 BIO International Convention's Innovation Corridor To Highlight The Future Of Biotechnology
Added: 26 мая 2008
Last relative articles:
- O'Keefe Receives Gruber Neuroscience Prize For Discovery Of Place Cells And Their Role In Cognition
- Seminar Focuses On Quality And Safety In Nursing Education, Illinois, USA
- UO Team's Findings Could Pave Way For Synthetic Compounds Useful In Drug Discovery And Materials Science
- Former President George Bush And Barbara Bush Lead C-Change Initiative To Unify Public Education Messages On Cancer Prevention And Early Detection
- Published Study Reveals Next Pharmaceuticals' Flavoxine trade; Reduces Multiple Heart Health Risk Factors Including High Cholesterol
- AquaSlim Helps You Get The Summer You Deserve -- Drink Thin With New AquaSlim
- Market America Announces Plans To Launch Vitamins For Children With Autism
- Wedensky Modulation Identifies Sudden Cardiac Arrest Risk In Patients
- VitalCare's Patient Of The Month Program Launch
- A New Approach To Epilepsy Treatment Takes Its First Steps
Comments: [0] / Post comment:
02 Dec 2008 03:35:26
Steering Committee Starts Work on AgBiotech Strategy for North ... - BioRegion News
Steering Committee Starts Work on AgBiotech Strategy for North ... BioRegion News, NY - 1 to begin work on a policy strategy for growing agricultural biotechnology in North Carolina, drawing on the states established life-sci industry and ...
02 Dec 2008 01:38:22
Enzon drops plan to spin off biotech business - Forbes
Enzon drops plan to spin off biotech business Forbes, NY - AP , 12.01.08, 06:26 PM EST Drugmaker Enzon Pharmaceuticals Inc. said Monday it called off plans to spin off its biotechnology division into an independent ...
02 Dec 2008 00:36:37
Leading Korean Biotech Company & Advanced Cell Technology Form JV - MarketWatch
Leading Korean Biotech Company & Advanced Cell Technology Form JV MarketWatch - and CHA Biotech Co, Ltd. (CHA), a leading Korean-based biotechnology company focused on the development of stem cell technologies, announced today the ...
02 Dec 2008 00:04:32
Enzon Discontinues Its Plan to Spin-off Its Biotechnology Business - WELT ONLINE
WELT ONLINE Enzon Discontinues Its Plan to Spin-off Its Biotechnology Business WELT ONLINE, Germany - "While we continue to believe that the spin-off of the biotechnology business would be a strategic and value-enhancing plan, the current external market ...01 Dec 2008 21:10:34
Scientist Albert Sasson Highlights Cubas Biotechnology Achievements - Cuba News
Cuba News Scientist Albert Sasson Highlights Cubas Biotechnology Achievements Cuba News, Cuba - HAVANA, Cuba, Dec 1 (acn) Cubas achievements in the field of biotechnology proves the political will, perseverance and responsibility maintained by the ...01 Dec 2008 18:30:37
An interactive discussion of current issues and technologies in ... - ScienceBlogs
An interactive discussion of current issues and technologies in ... ScienceBlogs - What's New in Life Science Research is managed and written entirely by Seed editors and expert guest bloggers. Read more about them here. ...
01 Dec 2008 17:37:39
UPDATE 1-Alkermes ends deal with Cephalon; raises '09 view - Reuters
UPDATE 1-Alkermes ends deal with Cephalon; raises '09 view Reuters - Dec 1 (Reuters) - Biotechnology company Alkermes Inc (ALKS.O: Quote, Profile, Research, Stock Buzz) said it regained the marketing rights for its treatment ... Alkermes Regains Full Commercialization Rights to VIVITROL(R) in US Alkermes (ALKS) Regains Full Commercial Rights to VIVITROL(R) in ... Alkermes takes over Vivitrol commercialization
01 Dec 2008 14:57:54
Vical gets $1 million payment from partner Merck - CNNMoney.com
Vical gets $1 million payment from partner Merck CNNMoney.com - NEW YORK (Associated Press) - Biotechnology company Vical Inc. said Monday it received a $1 million milestone payment from partner Merck & Co. after that ...
01 Dec 2008 07:07:33
Biotech firms cutting back as capital grows scarce - Boston Globe
Boston Globe Biotech firms cutting back as capital grows scarce Boston Globe, United States - Small and mid-size biotechnology firms are slashing jobs, cutting salaries, and shrinking their offices as it becomes increasingly difficult to raise ... Small cap biotech: The BAD (part I)01 Dec 2008 03:07:00
Neb. scientist sees role in selling biotechnology - NTV
Neb. scientist sees role in selling biotechnology NTV, NE - She says European opposition to biotechnology may be softening because of economic pressures and the success other parts of the world have had with ...